RYTHM, Inc.·4

Jun 18, 4:10 PM ET

Vakili Armon 4

4 · RYTHM, Inc. · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

RYTHM Director Vakili Armon Sells 2,250 Shares, Receives 5,000 RSUs

What Happened

  • Vakili Armon, a director of RYTHM, Inc. (RYM), sold a total of 2,250 shares in open-market transactions on June 17, 2026, generating approximately $59,676 in proceeds (105 shares @ $25.00 = $2,625; 1,705 shares @ $26.45 = $45,095; 440 shares @ $27.17 = $11,956).
  • The reporting person was also granted 5,000 restricted stock units (RSUs) on June 16, 2026, at no cash cost. The RSUs will vest 100% on the earlier of the one-year anniversary of the grant or the next annual meeting, subject to continued service.

Key Details

  • Transaction types: Award/Grant (A) — 5,000 RSUs on 2026-06-16; Sales (S) — 2,250 shares on 2026-06-17 (open market).
  • Sale prices: 105 shares @ $25.00; 1,705 shares reported at a weighted average $26.45 (individual trades ranged $26.07–$26.96); 440 shares reported at weighted average $27.17 (individual trades ranged $27.03–$27.41). The filer offers to provide a per-trade breakdown on request (see footnotes).
  • Proceeds from sales: ~$59,676 total.
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Vesting note: RSUs vest 100% on the earlier of one year after grant or the next annual meeting, contingent on continuous service (footnote).
  • Filing date: Form 4 filed 2026-06-18 for transactions on 06-16 and 06-17 — appears to be timely (Form 4 is generally due within two business days).

Context

  • Sales were open-market disposals (routine insider selling); the RSU award is a time-based grant that does not represent an immediate cash purchase.
  • There is no indication in the provided filing of option exercises, gifts, tax-withholding share forfeitures, or a 10% owner status.
  • Retail investors often regard purchases more strongly than routine sales; the RSU grant is compensation-related and will vest later rather than signaling immediate insider buying.

Insider Transaction Report

Form 4
Period: 2026-06-16
Vakili Armon
Director
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-16+5,00013,100 total
  • Sale

    Common Stock

    2026-06-17$25.00/sh105$2,62512,995 total
  • Sale

    Common Stock

    [F2]
    2026-06-17$26.45/sh1,705$45,09511,290 total
  • Sale

    Common Stock

    [F3]
    2026-06-17$27.17/sh440$11,95610,850 total
Footnotes (3)
  • [F1]Award granted in the form of restricted stock units under the issuer's 2022 Omnibus Equity Incentive Plan, as amended. 100% of the restricted stock units will vest on the earlier of (i) the one year anniversary of the date of the grant of the restricted stock units and (ii) the next annual meeting of the stockholders of the issuer following the date of the grant of the restricted stock units, subject to the reporting person's continuous service to the issuer through such vesting date.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.07 to $26.96, inclusive. The reporting person hereby undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.03 to $27.41, inclusive.
Signature
/s/ Kathryn A. Lloyd, Attorney-in-Fact|2026-06-18

Documents

1 file
  • 4
    form4-06182026_080652.xmlPrimary